Abiopharma

🔍 Schwartz Todd G. (Executive)

Company: OppFi Inc. (OPFI)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 208,053 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: false | shares_owned_after: 329,480.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,643 shares of Class A Common Stock at $7.71 per share (Direct)
  Date: 2026-04-02 | Code: F | equity_swap_involved: false | shares_owned_after: 326,837.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 17,987 shares of Class A Common Stock at $7.71 per share (Direct)
  Date: 2026-04-02 | Code: F | equity_swap_involved: false | shares_owned_after: 308,850.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By TGS Revocable Trust | shares_owned_after: 433,733.00 | Footnotes: F3

Footnotes:

• F1: Restricted stock units ("RSUs") granted pursuant to the OppFi Inc. 2021 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of OppFi Inc. Class A Common Stock, par value $0.0001 per share. 25% of the RSUs vested immediately on the date of grant and the remainder will vest in equal quarterly increments over the following three years, subject to the reporting person's continued service with the issuer and the terms of the Plan.
• F2: Represents shares withheld to cover tax withholding obligations upon the settlement of vested RSUs.
• F3: The reporting person is the sole trustee of TGS Revocable Trust.